Diabetes Care, Vol 18, Issue 3 361-376, Copyright © 1995 by American Diabetes Association

ARTICLES

Implementation of treatment protocols in the Diabetes Control and Complications Trial

OBJECTIVE--To describe the methods used to implement intensive and conventional therapies in the Diabetes Control and Complications Trial (DCCT) and the metabolic results that occurred with the different treatment regimens. RESEARCH DESIGN AND METHODS--The DCCT was a controlled clinical trial that demonstrated the beneficial effect of intensive therapy on the long-term complications of insulin-dependent diabetes mellitus (IDDM). A total of 1,441 volunteers with IDDM, aged 13-39, from 29 centers in the U.S. and Canada, were randomly assigned to conventional or intensive diabetes therapy. Intensive therapy, which used multiple daily injections (MDI) of insulin ( > or = 3 injections/day) or continuous subcutaneous insulin infusion (CSII), was implemented by a team that included diabetes nurses, dietitians, behavioral experts, and diabetologists. Volunteers in the intensive treatment group could use MDI or CSII, based on patient and clinic preference, and could switch between therapies over the course of the study. The volunteers were followed for a mean of 6.5 years (range 3-9 years). RESULTS--A detailed analysis of implementation of the two treatments indicates that intensive and conventional treatment subjects adhered to their respective insulin injection regimens > 97% of the time. Adherence to other elements of intensive treatment was similarly high and resulted in median HbA1c values between 6.7 and 7.2, compared with 8.7-9.2 with conventional therapy, over the course of the study. Severe hypoglycemia occurred three times more often in intensively treated subjects. Although subjects on intensive treatment were not randomly assigned to MDI or CSII, we compared those subjects who used either of these methods for > or = 90% of the study time. CSII-treated patients maintained a mean HbA1c of 6.8 vs. 7.0 in MDI-treated subjects during the trial (P < 0.05). The frequency of hypoglycemia with coma and seizure and diabetic ketoacidosis was modestly higher with CSII than with MDI. CONCLUSIONS--Intensive therapy was implemented successfully in the DCCT. The detailed description herein will serve to facilitate translation of the DCCT results to the clinical setting.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Velisek, J. Veliskova, O. Chudomel, K.-L. Poon, K. Robeson, B. Marshall, A. Sharma, and S. L. Moshe Metabolic Environment in Substantia Nigra Reticulata Is Critical for the Expression and Control of Hypoglycemia-Induced Seizures J. Neurosci., September 17, 2008; 28(38): 9349 - 9362. [Abstract] [Full Text] [PDF]

				R. E. Carter, D. T. Lackland, P. A. Cleary, E. Yim, M. F. Lopes-Virella, G. E. Gilbert, T. J. Orchard, and for the Diabetes Control and Complications Trial/E Intensive Treatment of Diabetes Is Associated With a Reduced Rate of Peripheral Arterial Calcification in The Diabetes Control and Complications Trial Diabetes Care, October 1, 2007; 30(10): 2646 - 2648. [Full Text] [PDF]

				J. W. Albers, W. H. Herman, R. Pop-Busui, C. L. Martin, P. Cleary, B. Waberski, and for the Diabetes Control and Complications Trial ( Subclinical Neuropathy Among Diabetes Control and Complications Trial Participants Without Diagnosable Neuropathy at Trial Completion: Possible predictors of incident neuropathy? Diabetes Care, October 1, 2007; 30(10): 2613 - 2618. [Abstract] [Full Text] [PDF]

				A. D. Paterson, B. N. Rutledge, P. A. Cleary, J. M. Lachin, R. S. Crow, and for the Diabetes Control and Complications Trial/E The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Diabetes Care, August 1, 2007; 30(8): 2107 - 2112. [Abstract] [Full Text] [PDF]

				The Mount Hood 4 Modeling Group Computer Modeling of Diabetes and Its Complications: A report on the Fourth Mount Hood Challenge Meeting Diabetes Care, June 1, 2007; 30(6): 1638 - 1646. [Abstract] [Full Text] [PDF]

				E. B. Fisher, C. A. Brownson, M. L. O'Toole, and V. V. Anwuri Ongoing Follow-up and Support for Chronic Disease Management in the Robert Wood Johnson Foundation Diabetes Initiative The Diabetes Educator, June 1, 2007; 33(Supplement_6): 201S - 207S. [Abstract] [Full Text] [PDF]

				D. M. Nathan Counterpoint: No Time to Inhale: Arguments Against Inhaled Insulin in 2007 Diabetes Care, February 1, 2007; 30(2): 442 - 443. [Full Text] [PDF]

				C. Mensing, J. Boucher, M. Cypress, K. Weinger, K. Mulcahy, P. Barta, G. Hosey, W. Kopher, A. Lasichak, B. Lamb, et al. National Standards for Diabetes Self-Management Education Diabetes Care, January 1, 2007; 30(suppl_1): S96 - S103. [Full Text] [PDF]

				D. A. Antonetti, A. J. Barber, S. K. Bronson, W. M. Freeman, T. W. Gardner, L. S. Jefferson, M. Kester, S. R. Kimball, J. K. Krady, K. F. LaNoue, et al. Diabetic Retinopathy: Seeing Beyond Glucose-Induced Microvascular Disease Diabetes, September 1, 2006; 55(9): 2401 - 2411. [Abstract] [Full Text] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF]

				J. C. Pickup Point: Are Insulin Pumps Underutilized in Type 1 Diabetes? Yes. Diabetes Care, June 1, 2006; 29(6): 1449 - 1452. [Full Text] [PDF]

				R. Nimri, N. Weintrob, H. Benzaquen, R. Ofan, G. Fayman, and M. Phillip Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Pediatrics, June 1, 2006; 117(6): 2126 - 2131. [Abstract] [Full Text] [PDF]

				L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF]

				C. L. Martin, J. Albers, W. H. Herman, P. Cleary, B. Waberski, D. A. Greene, M. J. Stevens, and E. L. Feldman Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion Diabetes Care, February 1, 2006; 29(2): 340 - 344. [Abstract] [Full Text] [PDF]

				C. Mensing, J. Boucher, M. Cypress, K. Weinger, K. Mulcahy, P. Barta, G. Hosey, W. Kopher, A. Lasichak, B. Lamb, et al. National Standards for Diabetes Self-Management Education Diabetes Care, January 1, 2006; 29(suppl_1): S78 - S85. [Full Text] [PDF]

				E. B. Fisher, C. A. Brownson, M. L. O'Toole, G. Shetty, V. V. Anwuri, and R. E. Glasgow Ecological Approaches to Self-Management: The Case of Diabetes Am J Public Health, September 1, 2005; 95(9): 1523 - 1535. [Abstract] [Full Text] [PDF]

				G. L. Warnock, R. M. Meloche, D. Thompson, R. J. Shapiro, M. Fung, Z. Ao, S. Ho, Z. He, L.-J. Dai, L. Young, et al. Improved Human Pancreatic Islet Isolation for a Prospective Cohort Study of Islet Transplantation vs Best Medical Therapy in Type 1 Diabetes Mellitus Arch Surg, August 1, 2005; 140(8): 735 - 744. [Abstract] [Full Text] [PDF]

				J. S. Skyler, R. S. Weinstock, P. Raskin, J.-F. Yale, E. Barrett, J. E. Gerich, H. C. Gerstein, and the Inhaled Insulin Phase III Type 1 Diabetes Stud Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial Diabetes Care, July 1, 2005; 28(7): 1630 - 1635. [Abstract] [Full Text] [PDF]

				C. Mensing, J. Boucher, M. Cypress, K. Weinger, K. Mulcahy, P. Barta, G. Hosey, W. Kopher, A. Lasichak, B. Lamb, et al. National Standards for Diabetes Self-Management Education Diabetes Care, January 1, 2005; 28(suppl_1): S72 - S79. [Full Text] [PDF]

				R. Retnakaran, J. Hochman, J. H. DeVries, H. Hanaire-Broutin, R. J. Heine, V. Melki, and B. Zinman Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The impact of baseline A1c Diabetes Care, November 1, 2004; 27(11): 2590 - 2596. [Abstract] [Full Text] [PDF]

				P. Hammond Continuous subcutaneous insulin infusion: short-term benefits apparent, long-term benefits speculative The British Journal of Diabetes & Vascular Disease, March 1, 2004; 4(2): 104 - 108. [Abstract] [PDF]

				J. S Skyler DCCT: the study that forever changed the nature of treatment of type 1 diabetes: Diabetes Control and Complications Trial -- a glycaemic control study in type 1 diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2004; 4(1): 29 - 32. [PDF]

				C. Mensing, J. Boucher, M. Cypress, K. Weinger, K. Mulcahy, P. Barta, G. Hosey, W. Kopher, A. Lasichak, B. Lamb, et al. National Standards for Diabetes Self-Management Education Diabetes Care, January 1, 2004; 27(90001): s143 - 143. [Full Text] [PDF]

				K. A. Goatman, M. J. Cree, J. A. Olson, J. V. Forrester, and P. F. Sharp Automated Measurement of Microaneurysm Turnover Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5335 - 5341. [Abstract] [Full Text] [PDF]

				P. Raskin, B. W. Bode, J. B. Marks, I. B. Hirsch, R. L. Weinstein, J. B. McGill, G. E. Peterson, S. R. Mudaliar, and R. R. Reinhardt Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Therapy Are Equally Effective in Type 2 Diabetes: A randomized, parallel-group, 24-week study Diabetes Care, September 1, 2003; 26(9): 2598 - 2603. [Abstract] [Full Text] [PDF]

				N. Weintrob, H. Benzaquen, A. Galatzer, S. Shalitin, L. Lazar, G. Fayman, P. Lilos, Z. Dickerman, and M. Phillip Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens in Children With Type 1 Diabetes: A Randomized Open Crossover Trial Pediatrics, September 1, 2003; 112(3): 559 - 564. [Abstract] [Full Text] [PDF]

				J. Weissberg-Benchell, J. Antisdel-Lomaglio, and R. Seshadri Insulin Pump Therapy: A meta-analysis Diabetes Care, April 1, 2003; 26(4): 1079 - 1087. [Abstract] [Full Text] [PDF]

				B. Guerci, M. Benichou, M. Floriot, P. Bohme, S. Fougnot, P. Franck, and P. Drouin Accuracy of an Electrochemical Sensor for Measuring Capillary Blood Ketones by Fingerstick Samples During Metabolic Deterioration After Continuous Subcutaneous Insulin Infusion Interruption in Type 1 Diabetic Patients Diabetes Care, April 1, 2003; 26(4): 1137 - 1141. [Abstract] [Full Text] [PDF]

				R. Amin, K. Ross, C. L. Acerini, J. A. Edge, J. Warner, and D. B. Dunger Hypoglycemia Prevalence in Prepubertal Children With Type 1 Diabetes on Standard Insulin Regimen: Use of Continuous Glucose Monitoring System Diabetes Care, March 1, 2003; 26(3): 662 - 667. [Abstract] [Full Text] [PDF]

				S Nordfeldt, C Johansson, E Carlsson, and J-A Hammersjo Prevention of severe hypoglycaemia in type I diabetes: a randomised controlled population study Arch. Dis. Child., March 1, 2003; 88(3): 240 - 245. [Abstract] [Full Text] [PDF]

				C. Mensing, J. Boucher, M. Cypress, K. Weinger, K. Mulcahy, P. Barta, G. Hosey, W. Kopher, A. Lasichak, B. Lamb, et al. National Standards for Diabetes Self-Management Education Diabetes Care, January 1, 2003; 26(90001): s149 - 156. [Full Text] [PDF]

				L. Meyer, P. Bohme, I. Delbachian, P. Lehert, N. Cugnardey, P. Drouin, and B. Guerci The Benefits of Metformin Therapy During Continuous Subcutaneous Insulin Infusion Treatment of Type 1 Diabetic Patients Diabetes Care, December 1, 2002; 25(12): 2153 - 2158. [Abstract] [Full Text] [PDF]

				G. L. Booth, B. Zinman, and D. A. Redelmeier Diabetes Care in the U.S. and Canada Diabetes Care, July 1, 2002; 25(7): 1149 - 1153. [Abstract] [Full Text] [PDF]

				The Writing Team for the Diabetes Control and Comp Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes Mellitus JAMA, May 15, 2002; 287(19): 2563 - 2569. [Abstract] [Full Text] [PDF]

				B. Bode, R. Weinstein, D. Bell, J. McGill, D. Nadeau, P. Raskin, J. Davidson, R. Henry, W.-C. Huang, and R. R. Reinhardt Comparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin Infusion: A randomized study in type 1 diabetes Diabetes Care, March 1, 2002; 25(3): 439 - 444. [Abstract] [Full Text] [PDF]

				J. Pickup and H. Keen Continuous Subcutaneous Insulin Infusion at 25 Years: Evidence base for the expanding use of insulin pump therapy in type 1 diabetes Diabetes Care, March 1, 2002; 25(3): 593 - 598. [Abstract] [Full Text] [PDF]

				M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF]

				M. J. Lenhard and G. D. Reeves Continuous Subcutaneous Insulin Infusion: A Comprehensive Review of Insulin Pump Therapy Arch Intern Med, October 22, 2001; 161(19): 2293 - 2300. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial Resea Influence of Intensive Diabetes Treatment on Body Weight and Composition of Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial Diabetes Care, October 1, 2001; 24(10): 1711 - 1721. [Abstract] [Full Text] [PDF]

				J. Pickup and H. Keen Continuous subcutaneous insulin infusion in type 1 diabetes BMJ, May 26, 2001; 322(7297): 1262 - 1263. [Full Text] [PDF]

				E. Koll and J. B. Hewitt Adherence to 1997 Diabetes Screening Guidelines in a Large Ambulatory Clinic The Diabetes Educator, May 1, 2001; 27(3): 387 - 392. [Abstract] [PDF]

				A. K. Maniatis, G. J. Klingensmith, R. H. Slover, C. J. Mowry, and H. P. Chase Continuous Subcutaneous Insulin Infusion Therapy for Children and Adolescents: An Option for Routine Diabetes Care Pediatrics, February 1, 2001; 107(2): 351 - 356. [Abstract] [Full Text]

				B. W. Bode and P. Strange Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes Diabetes Care, January 1, 2001; 24(1): 69 - 72. [Abstract] [Full Text]

				A. E. Kitabchi, G. E. Umpierrez, M. B. Murphy, E. J. Barrett, R. A. Kreisberg, J. I. Malone, and B. M. Wall Management of Hyperglycemic Crises in Patients With Diabetes Diabetes Care, January 1, 2001; 24(1): 131 - 153. [Full Text]

				C. Mensing, J. Boucher, M. Cypress, K. Weinger, K. Mulcahy, P. Barta, O. Hosey, W. Kopher, A. Lasichak, B. Lamb, et al. National Standards for Diabetes Self-Management Education The Diabetes Educator, July 1, 2000; 26(4): 611 - 626. [PDF]

				M. Berger and I. Muhlhauser Diabetes Care and Patient-Oriented Outcomes JAMA, May 12, 1999; 281(18): 1676 - 1678. [Full Text] [PDF]

				The Diabetes Control and Complications Trial Resea Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial Arch Ophthalmol, July 1, 1998; 116(7): 874 - 886. [Abstract] [Full Text] [PDF]

				E. Boland, J. Ahern, and M. Grey A Primer on the Use of Insulin Pumps in Adolescents The Diabetes Educator, January 1, 1998; 24(1): 78 - 86. [PDF]

				S. Genuth Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus Ann Intern Med, January 1, 1996; 124(1_Part_2): 104 - 109. [Abstract] [Full Text]